BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Colao A, Faggiano A, Pivonello R. Somatostatin analogues: treatment of pituitary and neuroendocrine tumors. Prog Brain Res 2010;182:281-94. [PMID: 20541670 DOI: 10.1016/S0079-6123(10)82012-6] [Cited by in Crossref: 24] [Cited by in F6Publishing: 25] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Liu K, Zhuang J. Adrenal neuroendocrine carcinoma not responsive to EP regimen (cisplatin and etoposide). Medicine: Case Reports and Study Protocols 2022;3:e0201. [DOI: 10.1097/md9.0000000000000201] [Reference Citation Analysis]
2 Schonbrunn A, Kitainda V. Receptors | Somatostatin Receptors. Encyclopedia of Biological Chemistry III 2021. [DOI: 10.1016/b978-0-12-819460-7.00167-5] [Reference Citation Analysis]
3 Yokota K, Kurihara I, Matsusaka Y, Emoto K, Hishida T, Oshida T, Kobayashi S, Murai-Takeda A, Miyashita K, Matsuda K, Nakagomi T, Matsuda K, Itoh H. Mediastinal Cystic Parathyroid Adenoma Diagnosed by Somatostatin Receptor Scintigraphy. Intern Med 2021;60:1555-60. [PMID: 33281167 DOI: 10.2169/internalmedicine.6381-20] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
4 Herrera-Martínez AD, Hofland J, Hofland LJ, Brabander T, Eskens FALM, Gálvez Moreno MA, Luque RM, Castaño JP, de Herder WW, Feelders RA. Targeted Systemic Treatment of Neuroendocrine Tumors: Current Options and Future Perspectives. Drugs 2019;79:21-42. [PMID: 30560479 DOI: 10.1007/s40265-018-1033-0] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 8.8] [Reference Citation Analysis]
5 Pivonello C, Rousaki P, Negri M, Sarnataro M, Napolitano M, Marino FZ, Patalano R, De Martino MC, Sciammarella C, Faggiano A, Rocco G, Franco R, Kaltsas GA, Colao A, Pivonello R. Effects of the single and combined treatment with dopamine agonist, somatostatin analog and mTOR inhibitors in a human lung carcinoid cell line: an in vitro study. Endocrine 2017;56:603-20. [PMID: 27688013 DOI: 10.1007/s12020-016-1079-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
6 Lehmann A, Kliewer A, Günther T, Nagel F, Schulz S. Identification of Phosphorylation Sites Regulating sst3 Somatostatin Receptor Trafficking. Mol Endocrinol 2016;30:645-59. [PMID: 27101376 DOI: 10.1210/me.2015-1244] [Cited by in Crossref: 14] [Cited by in F6Publishing: 16] [Article Influence: 2.0] [Reference Citation Analysis]
7 Broder MS, Beenhouwer D, Strosberg JR, Neary MP, Cherepanov D. Gastrointestinal neuroendocrine tumors treated with high dose octreotide-LAR: A systematic literature review. World J Gastroenterol 2015; 21(6): 1945-1955 [PMID: 25684964 DOI: 10.3748/wjg.v21.i6.1945] [Cited by in CrossRef: 56] [Cited by in F6Publishing: 62] [Article Influence: 7.0] [Reference Citation Analysis]
8 Bram Z, Xekouki P, Louiset E, Keil MF, Avgeropoulos D, Giatzakis C, Nesterova M, Sinaii N, Hofland LJ, Cherqaoui R, Lefebvre H, Stratakis CA. Does somatostatin have a role in the regulation of cortisol secretion in primary pigmented nodular adrenocortical disease (ppnad)? a clinical and in vitro investigation. J Clin Endocrinol Metab 2014;99:E891-901. [PMID: 24512486 DOI: 10.1210/jc.2013-2657] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
9 Zeglis BM, Houghton JL, Evans MJ, Viola-Villegas N, Lewis JS. Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals. Inorg Chem 2014;53:1880-99. [PMID: 24313747 DOI: 10.1021/ic401607z] [Cited by in Crossref: 64] [Cited by in F6Publishing: 68] [Article Influence: 6.4] [Reference Citation Analysis]
10 Schonbrunn A. Somatostatin Receptors. Encyclopedia of Biological Chemistry 2013. [DOI: 10.1016/b978-0-12-378630-2.00391-1] [Reference Citation Analysis]
11 Fleseriu M. Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review. Pituitary 2011;14:184-93. [PMID: 21161602 DOI: 10.1007/s11102-010-0282-z] [Cited by in Crossref: 59] [Cited by in F6Publishing: 44] [Article Influence: 4.9] [Reference Citation Analysis]
12 Tower-Gilchrist C, Lee E, Sztul E. Endosomal trafficking of the G protein-coupled receptor somatostatin receptor 3. Biochem Biophys Res Commun 2011;413:555-60. [PMID: 21925142 DOI: 10.1016/j.bbrc.2011.08.137] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 0.9] [Reference Citation Analysis]
13 Kao YJ, Ghosh M, Schonbrunn A. Ligand-dependent mechanisms of sst2A receptor trafficking: role of site-specific phosphorylation and receptor activation in the actions of biased somatostatin agonists. Mol Endocrinol 2011;25:1040-54. [PMID: 21493671 DOI: 10.1210/me.2010-0398] [Cited by in Crossref: 43] [Cited by in F6Publishing: 44] [Article Influence: 3.6] [Reference Citation Analysis]